A PROSPECTIVE RANDOMIZED TRIAL OF HLA-MATCHED VERSUS MISMATCHED SINGLE-DONOR PLATELET TRANSFUSIONS IN CANCER-PATIENTS

被引：0
|
作者：
MESSERSCHMIDT, GL [1 ]
MAKUCH, R [1 ]
APPELBAUM, F [1 ]
UNGERLEIDER, RS [1 ]
ABRAMS, R [1 ]
ODONNELL, J [1 ]
HOLOHAN, TV [1 ]
FONTANA, J [1 ]
WRIGHT, D [1 ]
ANAGNOU, NP [1 ]
SHAN, TC [1 ]
CHESBRO, B [1 ]
DEISSEROTH, AB [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,BIOMET RES BRANCH,BETHESDA,MD 20205
来源：
CANCER | 1988年 / 62卷 / 04期
关键词：
D O I：
10.1002/1097-0142(19880815)62:4<795::AID-CNCR2820620426>3.0.CO;2-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：795 / 801
页数：7
相关论文
共 50 条
  • [21] A PROSPECTIVE RANDOMIZED TRIAL COMPARING THE INFECTIOUS AND NONINFECTIOUS COMPLICATIONS OF AN EXTERNALIZED CATHETER VERSUS A SUBCUTANEOUSLY IMPLANTED DEVICE IN CANCER-PATIENTS
    MUELLER, BU
    SKELTON, J
    CALLENDER, DPE
    MARSHALL, D
    GRESS, J
    LONGO, D
    NORTON, J
    RUBIN, M
    VENZON, D
    PIZZO, PA
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) : 1943 - 1948
  • [22] Randomised, Non-inferiority Trial of HLA Epitope Matched Platelet Transfusions for Alloimmunised Patients with Myeloid Bone Marrow Disorders
    Marsh, J.
    Pankhurst, L.
    Kallon, D.
    Brown, C.
    Gilbertson, A.
    Pigden, C.
    Deary, A. J.
    Mora, A.
    Brown, J.
    Liang, E.
    Choo, C. J.
    Hodge, R. L.
    Llwewlyn, C.
    Harding, K.
    Sage, D.
    Mijovic, A.
    Mufti, G. J.
    Stanworth, S. J.
    Navarrate, C. V.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 33 - 33
  • [23] SINGLE AGENT THERAPY FOR INFECTIONS IN CANCER-PATIENTS - A PROSPECTIVE RANDOMIZED TRIAL COMPARING 3 EXTENDED-SPECTRUM CEPHALOSPORINS
    ROLSTON, KVI
    JONES, PG
    FAINSTEIN, V
    KHARDORI, NM
    ANAISSIE, EJ
    STEELHAMMER, L
    BODEY, GP
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (03) : 139 - 145
  • [24] Retroperitoneal Single Port Versus Transperitoneal Multiport Donor Nephrectomy: A Prospective Randomized Control Trial
    Chauhan, Neelam
    Kenwar, Deepesh Benjamin
    Singh, Navdeep
    Singh, Sarbpreet
    Sharma, Ashish
    Kapoor, Kunal
    Kumar, Sandeep
    JOURNAL OF ENDOUROLOGY, 2018, 32 (06) : 496 - 501
  • [25] Prospective, Multicenter Clinical Trial of Atorvastatin-Based Acute Graft-Versus-Host-Disease (aGVHD) Prophylaxis in Recipients of HLA-Matched Related Donor (MRD) and Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
    Hamadani, Mehdi
    Pasquini, Marcelo C.
    Visotcky, Alexis
    Ahn, Kwang Woo
    Horowitz, Mary M.
    Boyd, Jennifer
    Rizzo, J. Douglas
    Saber, Wael
    Drobyski, William
    Arce-lara, Carlos
    D'Souza, Anita
    Fenske, Timothy S.
    Cumpston, Aaron
    Bunner, Pamela
    Craig, Michael
    Hari, Parameswaran N.
    Kanate, Abraham S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S47 - S48
  • [26] HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison
    Devillier, Raynier
    Legrand, Faezeh
    Rey, Jerome
    Castagna, Luca
    Furst, Sabine
    Granata, Angela
    Charbonnier, Aude
    Harbi, Samia
    d'Incan, Evelyne
    Pagliardini, Thomas
    Faucher, Catherine
    Lemarie, Claude
    Saillard, Colombe
    Calmels, Boris
    Mohty, Bilal
    Maisano, Valerio
    Weiller, Pierre-Jean
    Chabannon, Christian
    Vey, Norbert
    Blaise, Didier
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (07) : 1449 - 1454
  • [27] Comparing between HLA-matched sibling donor allogenic HSCT and non-sibling matched related donor allogenic HSCT outcome in pediatric patients; single center retrospective study
    Essa, Mohammed F.
    Alghazwani, Sarah
    Abujoub, Rodaina
    Memon, Shahbaz
    Alkaiyat, Mohammed
    Ardah, Husam
    Alsultan, Abdulrahman
    PEDIATRIC TRANSPLANTATION, 2024, 28 (01)
  • [28] No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy
    Schober, Sebastian Johannes
    Hallmen, Erika
    Ressle, Florian
    Gassmann, Hendrik
    Prexler, Carolin
    Wawer, Angela
    von Luettichau, Irene
    Ladenstein, Ruth
    Kazanowska, Bernarda
    Ljungman, Gustaf
    Niggli, Felix
    Lohi, Olli
    Hauer, Julia
    Gruhn, Bernd
    Klingebiel, Thomas
    Bader, Peter
    Burdach, Stefan
    Lang, Peter
    Sparber-Sauer, Monika
    Koscielniak, Ewa
    Thiel, Uwe
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation
    Lee, Myung-Won
    Yeon, Sang Hoon
    Seo, Won-Hyoung
    Ryu, Hyewon
    Lee, Hyo-Jin
    Yun, Hwan-Jung
    Jo, Deog-Yeon
    Song, Ik-Chan
    MEDICINE, 2020, 99 (34) : E21571
  • [30] Impact of stem cell source on graft-versus-host disease and non-relapse mortality: comparison of 10/10 HLA-matched unrelated donor with 9/10 HLA-mismatched unrelated donor and cord blood transplants
    Granier, C.
    Masson, E.
    Biard, L.
    Porcher, R.
    de Latour, R. Peffault
    Robin, M.
    Xhaard, A.
    Ribaud, P.
    Loiseau, P.
    Charron, D.
    Socie, G.
    Dhedin, N.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S92 - S93
12345